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ABSTRACT
Background. The improved prognosis of early preterm birth has created a generation of
surviving small preterm infants whose health needs in adulthood are poorly known.
Epidemiological studies in subjects born at term have repeatedly shown an association
between small size at birth and increased risk of adult cardiovascular disease. While
considerable variation in this risk is already related to small differences within the normal
range of size at birth, small preterm infants frequently exhibit severe postnatal or prenatal
growth retardation, or both, and are often exposed to growth-inhibiting treatments such as
glucocorticoids. There is thus reason for serious concern about increased cardiovascular risk
when surviving small preterm infants become older.
Endocrine programming – lifelong effects of early nutrition and hormonal milieu on
endocrine systems such as the insulin-like growth factor (IGF) system and the
hypothalamic-pituitary-adrenal axis (HPAA) – is likely to play a major role in linking size
at birth with adult disease. Because direct assessment of late-life health in small preterm
infants would require decades of follow-up, we studied endocrine mechanisms of growth in
two distant parts of the life span: in small preterm infants and in 65- to 75-year-old adults
with birth and childhood measurements recorded. Our secondary aim was to find a
biochemical indicator of growth velocity for small preterm infants.
Subjects and methods. Cord vein IGFs and IGF-binding proteins (IGFBPs) as well as
markers of collagen turnover were studied in 98 infants born at <32 weeks’ gestation. Forty-
eight infants with birthweight < 1500 g underwent a 9-week follow-up with repeated
determinations of these factors and a rigorous protocol of frequent, accurate weight and
lower leg length measurements (knemometry). In 107 infants of <32 weeks’ gestation,
placental 11β-HSD2 activity [enzyme converting active cortisol (F) to inactive cortisone
(E)] was measured together with cord vein F and E concentrations.
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In the adult study, 421 men and women born at term, now aged 65 to 75 years,
underwent total and free F, IGF-I and IGFBP-1 measurements in conjunction with a detailed
clinical examination.
Results. In small preterm infants, IGF-I and IGFBP-3 were associated with relative
birthweight (r=0.58, p<0.0001 and r=0.44, p<0.0001, respectively) and postnatal growth
velocity, and IGFBP-1 was inversely correlated with relative birth weight (r=-0.50,
p<0.0001). In adults, high IGF-I and low IGFBP-1 were associated with impaired glucose
tolerance and elevated blood pressure, whereas low IGF-I was associated with increased
waist circumference and percentage body fat. IGF-I was unrelated to birth measurements,
while IGFBP-1 was correlated with birthweight (r=0.11, p=0.03). Tall height and high body
mass index at 7 years predicted low IGF-I and high IGFBP-1 in adulthood, but only in
subjects of low adult lean body mass.
The most robust indicator of growth velocity in small preterm infants was the ratio of
marker of type I collagen degradation to a marker of its synthesis (ICTP / PINP ratio),
which may be sufficiently sensitive and specific for clinical use in detecting slow growth.
In small preterm infants, reduced inactivation of F to E by placental 11β-HSD2 was
associated with low relative birth weight (r=0.56, p<0.0001) and severe foetal distress
(p=0.02). Findings in adults showed complex interactions in the early determinants of
adulthood F concentration. In subjects born between 37 and 39 weeks’ gestation, low
birthweight was associated with high fasting total (p=0.02) and free (p=0.09) F in
adulthood, whereas in subjects born after 40 weeks’ gestation, the trend was inverse: low
birthweight predicted low fasting total (p=0.06) and free F (p=0.002) (p for
interaction = 0.01 for total and 0.003 for free cortisol).
Conclusions. Differences in circulating IGFs and IGFBPs as well as cortisol in 65- to
75-year-old subjects relate to minor variation in birth measurements and childhood growth.
These hormonal parameters show marked aberrations in small preterm infants, who
frequently suffer from pre- or postnatal growth restriction. This suggests that early life
programming of adulthood disease has the potential of becoming a major health burden
when the present-day small preterm infants become older. Our findings urge for systematic
long-term follow-up studies in small preterm survivors to assess the risk of cardiovascular
disease and other adverse health consequences and to search for preventive means.
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